CETI - Centro de Estudo em Terapias Inovadoras

Curitiba, Paraná 80030-110

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed